Table 3: Condensed consolidated statement of cash flows (unaudited)
| ($ in millions) | Three months ended | ||||||||||
| October 1, 2023 | July 2, 2023 | October 2, 2022 | |||||||||
| Cash flows from operating activities: | |||||||||||
| Net income (loss) | $ | 792 | $ | 704 | $ | 750 | |||||
| Adjustments to reconcile net income (loss) to net cash provided by (used for) operating activities: | |||||||||||
| Depreciation and amortization | 273 | 281 | 321 | ||||||||
| Share-based compensation | 103 | 102 | 89 | ||||||||
| Amortization of discount (premium) on debt, net | 1 | — | 1 | ||||||||
| Amortization of debt issuance costs | 2 | 2 | 2 | ||||||||
| Net (gain) loss on sale of assets | — | (1 | ) | (1 | ) | ||||||
| Results relating to equity-accounted investees | 2 | 1 | 4 | ||||||||
| (Gain) loss on equity securities, net | 4 | (6 | ) | 2 | |||||||
| Deferred tax expense (benefit) | (33 | ) | (75 | ) | (98 | ) | |||||
| Changes in operating assets and liabilities: | |||||||||||
| (Increase) decrease in receivables and other current assets | 40 | (20 | ) | (54 | ) | ||||||
| (Increase) decrease in inventories | (34 | ) | (129 | ) | (119 | ) | |||||
| Increase (decrease) in accounts payable and other liabilities | (128 | ) | (144 | ) | 275 | ||||||
| (Increase) decrease in other non-current assets | (49 | ) | 33 | (37 | ) | ||||||
| Exchange differences | 5 | 5 | 1 | ||||||||
| Other items | 10 | 3 | 8 | ||||||||
| Net cash provided by (used for) operating activities | 988 | 756 | 1,144 | ||||||||
| Cash flows from investing activities: | |||||||||||
| Purchase of identified intangible assets | (42 | ) | (51 | ) | (50 | ) | |||||
| Capital expenditures on property, plant and equipment | (200 | ) | (201 | ) | (282 | ) | |||||
| Proceeds from the disposals of property, plant and equipment | — | 1 | 1 | ||||||||
| Purchase of interests in businesses, net of cash acquired | — | — | (22 | ) | |||||||
| Purchase of investments | (31 | ) | (4 | ) | (7 | ) | |||||
| Proceeds from the sale of investments | — | — | — | ||||||||
| Net cash provided by (used for) investing activities | (273 | ) | (255 | ) | (360 | ) | |||||
| Cash flows from financing activities: | |||||||||||
| Dividends paid to common stockholders | (262 | ) | (264 | ) | (223 | ) | |||||
| Proceeds from issuance of common stock through stock plans | 36 | 1 | 30 | ||||||||
| Purchase of treasury shares and restricted stock unit withholdings | (306 | ) | (302 | ) | (366 | ) | |||||
| Other, net | (1 | ) | — | — | |||||||
| Net cash provided by (used for) financing activities | (533 | ) | (565 | ) | (559 | ) | |||||
| Effect of changes in exchange rates on cash positions | (3 | ) | (3 | ) | (11 | ) | |||||
| Increase (decrease) in cash and cash equivalents | 179 | (67 | ) | 214 | |||||||
| Cash and cash equivalents at beginning of period | 3,863 | 3,930 | 3,545 | ||||||||
| Cash and cash equivalents at end of period | 4,042 | 3,863 | 3,759 | ||||||||
| Net cash paid during the period for: | |||||||||||
| Interest | 38 | 86 | 39 | ||||||||
| Income taxes, net of refunds | 165 | 239 | 160 | ||||||||
| Net gain (loss) on sale of assets: | |||||||||||
| Cash proceeds from the sale of assets | — | 1 | 1 | ||||||||
| Non-cash investing activities: | |||||||||||
| Non-cash capital expenditures | 167 | 165 | 176 | ||||||||
